These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2429045)

  • 1. [Study of cerebrospinal fluid arginase activity in the diagnosis of amyotrophic lateral sclerosis].
    Khokhlov AP; Zavalishin IA; Savchenko IuN; Levchenko AG
    Lab Delo; 1986; (8):457-9. PubMed ID: 2429045
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amyotrophic lateral sclerosis: the biochemical aspects of its diagnosis and pathogenesis].
    Zavalishin IA; Khokhlov AP; Levchenko AG; Zakharova MN
    Vestn Akad Med Nauk SSSR; 1987; (2):50-3. PubMed ID: 3577377
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebrospinal fluid proteins in the course of amyotrophic lateral sclerosis].
    Castaigne P; Lhermitte F; Schuller E; Rouques C
    Rev Neurol (Paris); 1971 Nov; 125(5):393-400. PubMed ID: 4115435
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations of arginase activity in scrapie-infected mice and in amyotrophic lateral sclerosis.
    Roikhel VM; Fokina GI; Khokhlov AI; Sobolev SG; Zavalishin IA; Korolev MB; Pogodina VV
    Acta Virol; 1990 Dec; 34(6):545-53. PubMed ID: 1983181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Charcot's disease and juvenile amyotrophic lateral sclerosis].
    Ben Hamida M; Hentati F
    Rev Neurol (Paris); 1984; 140(3):202-6. PubMed ID: 6729330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical aspects of the pathogenesis of amyotrophic lateral sclerosis].
    Zavalishin IA; Khokhlov AP; Larskiĭ EG; Seĭfulla RD; Roĭkhel' VM
    Vestn Akad Med Nauk SSSR; 1988; (12):49-56. PubMed ID: 3071018
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid amino acids in amyotrophic lateral sclerosis.
    Kornhuber ME; Kornhuber J
    Ann Neurol; 1992 Apr; 31(4):449-50. PubMed ID: 1586146
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of amyotrophic lateral sclerosis syndrome with positive viral tests of the cerebrospinal fluid].
    Delsedime M; Mutani R; Giuliani G
    Acta Neurol (Napoli); 1974 Mar; 29(2):197-201. PubMed ID: 4368037
    [No Abstract]   [Full Text] [Related]  

  • 11. The problem of clinical forms and the course of amyotrophic lateral sclerosis. (Study of amyotrophic lateral sclerosis. XVII.).
    Sercl M; Kovarík J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(4):411-6. PubMed ID: 5238995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary results of determining the corticoliberin levels of the cerebrospinal fluid of patients with amyotrophic lateral sclerosis].
    Klimek A; Stepień H; Szulc-Kuberska J; Cieślak D
    Pol Tyg Lek; 1987 Nov; 42(45):1417-8. PubMed ID: 3502289
    [No Abstract]   [Full Text] [Related]  

  • 13. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ford L; Rowe D
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):118-20. PubMed ID: 15204013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z
    Neurol Sci; 2003 Nov; 24(4):273-4. PubMed ID: 14658047
    [No Abstract]   [Full Text] [Related]  

  • 18. [What usual and unusual clinical signs suggest amyotrophic lateral sclerosis?].
    Maugin D
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S14-4S16. PubMed ID: 17128084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis.
    Shahani N; Nalini A; Gourie-Devi M; Raju TR
    Exp Neurol; 1998 Jan; 149(1):295-8. PubMed ID: 9454639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.